Cargando…
Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice
PURPOSE: Vascular endothelial growth factor inhibitors (anti-VEGF) have been shown to be effective in the treatment of diabetic macular edema. However, there is little information about the systemic effects of intraocular administration of anti-VEGF drugs in patients with coexistent diabetic nephrop...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538817/ https://www.ncbi.nlm.nih.gov/pubmed/37530286 http://dx.doi.org/10.4103/IJO.IJO_44_23 |